Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Breast Cancer

Free Subscription 15.07.2024 1 AJR Am J Roentgenol 2 Ann Oncol 17 Ann Surg Oncol 1 BMC Cancer 1 BMJ 1 Br J Cancer 4 Breast Cancer 1 Breast Cancer (Dove Med Press) 1 Breast Cancer Res 12 Breast Cancer Res Treat 1 Cancer 1 Cancer Lett 1 Cancer Res 5 Clin Breast Cancer 1 Clin Cancer Res 1 Eur J Surg Oncol 2 Eur Radiol 1 Histopathology 2 Int J Cancer 1 J Clin Oncol 1 Nat Rev Cancer 2 NPJ Breast Cancer 1 Oncogene 1 Pathology 1 PLoS Comput Biol 2 PLoS One 1 Radiol Imaging Cancer

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. OUEIDAT K, Baird GL, Barclay-White B, Kozlowski K, et al
   Cryoablation of Primary Breast Cancer in Patients Ineligible for Clinical Trials: A Multiinstitutional Study.
   AJR Am J Roentgenol. 2024 Jul 10. doi: 10.2214/AJR.24.31392.
   PubMed         Abstract available
   
   

   
   Ann Oncol

2. FREEDMAN RA, Heiling HM, Li T, Trapani D, et al
   Neratinib and Ado-Trastuzumab-Emtansine for Pre-treated and Untreated HER2-positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium Trial 022.
   Ann Oncol. 2024 Jul 6:S0923-7534(24)01015-9. doi: 10.1016/j.annonc.2024.
   PubMed         Abstract available
   
   
3. ROWLANDS CF, Allen S, Balmana J, Domchek SM, et al
   Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing.
   Ann Oncol. 2024 Jul 8:S0923-7534(24)01014-7. doi: 10.1016/j.annonc.2024.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

4. WANG CS, Al-Nowaylati AR, Matusko N, Momoh AO, et al
   Simultaneous Co-surgeon Deep Inferior Epigastric Perforator (DIEP) Flap Breast Reconstructions: Feasibility and Clinical Outcomes.
   Ann Surg Oncol. 2024;31:5409-5416.
   PubMed         Abstract available
   
   
5. SHANNO JN, Daly AE, Anderman KJ, Santa Cruz HS, et al
   Positive Nipple Margins in Nipple-Sparing Mastectomy: Management of Nipples Containing Cancer or Atypia.
   Ann Surg Oncol. 2024;31:5148-5156.
   PubMed         Abstract available
   
   
6. HAMID SA, Bakkila B, Schultz KS, Grimshaw AA, et al
   "Peace of Mind" After Mastectomy: A Scoping Review.
   Ann Surg Oncol. 2024;31:5168-5179.
   PubMed         Abstract available
   
   
7. BEST CS, Kung TA
   ASO Author Reflections: Improving Patient Access to Autologous Breast Reconstruction.
   Ann Surg Oncol. 2024;31:5417-5418.
   PubMed        
   
   
8. WANG CS, Al-Nowaylati AR, Matusko N, Momoh AO, et al
   ASO Visual Abstract: Simultaneous Co-surgeon Deep Inferior Epigastric Perforator (DIEP) Flap Breast Reconstructions-Feasibility and Clinical Outcomes.
   Ann Surg Oncol. 2024;31:5419-5420.
   PubMed        
   
   
9. HAMID SA, Bakkila B, Schultz KS, Grimshaw AA, et al
   ASO Visual Abstract: "Peace of Mind" After Mastectomy: A Scoping Review.
   Ann Surg Oncol. 2024;31:5213-5214.
   PubMed        
   
   
10. SHANNO JN, Daly AE, Anderman KJ, Santa Cruz HS, et al
    ASO Visual Abstract: Positive Nipple Margins in Nipple Sparing Mastectomy-Management of Nipples Containing Cancer or Atypia.
    Ann Surg Oncol. 2024;31:5230.
    PubMed        
    
    
11. DALY AE, Anderman KJ, Smith BL
    ASO Author Reflections: Positive Nipple Margins in Nipple-Sparing Mastectomy: Management of Nipples Containing Cancer or Atypia.
    Ann Surg Oncol. 2024;31:5211-5212.
    PubMed        
    
    
12. FALADE I, Switalla K, Quirarte A, Baxter M, et al
    ASO Visual Abstract: Oncologic Safety of Immediate Oncoplastic Surgery Compared to Standard Breast Conserving Surgery for Patients with Invasive Lobular Carcinoma.
    Ann Surg Oncol. 2024;31:5004-5005.
    PubMed        
    
    
13. DI LENA E, Iny E, Wong SM, Bassel M, et al
    Impact of Margin Status on Local Recurrence in Patients with Breast Cancer Undergoing Breast-Conserving Surgery After Neoadjuvant Chemotherapy: A Retrospective Multi-Institutional Cohort Study.
    Ann Surg Oncol. 2024 Jul 5. doi: 10.1245/s10434-024-15716.
    PubMed         Abstract available
    
    
14. CHEUN JH, Chung S, Han JH, Lee YW, et al
    Surveillance for Distant Metastasis in Breast Cancer Patients Who Underwent Contemporary Management: A Report from the Korean Breast Cancer Society Survivor Research Group.
    Ann Surg Oncol. 2024 Jul 5. doi: 10.1245/s10434-024-15665.
    PubMed         Abstract available
    
    
15. BOTTY VAN DEN BRUELE A, Weiss A
    Updated Guidelines on When to Consider Germline Testing for Patients with Breast Cancer.
    Ann Surg Oncol. 2024 Jul 5. doi: 10.1245/s10434-024-15638.
    PubMed        
    
    
16. NTOWE KW, Thomas SM, Dalton JC, Olunuga E, et al
    Demographics and Clinical Decision Making in Patients with Germline Moderate Penetrance Non-BRCA Mutations in Breast Cancer Related Genes.
    Ann Surg Oncol. 2024 Jul 8. doi: 10.1245/s10434-024-15793.
    PubMed         Abstract available
    
    
17. DOLL A, Lipsyc-Sharf M, Sim MS, Baker JL, et al
    Outcome of Patients with Pregnancy-Associated Breast Cancer Who Have Subsequent Pregnancies.
    Ann Surg Oncol. 2024 Jul 10. doi: 10.1245/s10434-024-15798.
    PubMed         Abstract available
    
    
18. CARROLL JF, Hoskin TL, Hieken TJ
    Correlation of PET-CT Nodal Imaging and Pathologic Response to Neoadjuvant Immunotherapy for Node-Positive Breast Cancer.
    Ann Surg Oncol. 2024 Jul 10. doi: 10.1245/s10434-024-15826.
    PubMed        
    
    
19. BELLINI A, Sauder CAM
    ASO Author Reflections: Disparities Exist for Adolescent Young Adult Breast Cancer Survivors.
    Ann Surg Oncol. 2024 Jul 11. doi: 10.1245/s10434-024-15803.
    PubMed        
    
    
20. SWITALLA KM, Boughey JC, Dimitroff K, Yau C, et al
    Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial.
    Ann Surg Oncol. 2024 Jul 12. doi: 10.1245/s10434-024-15792.
    PubMed         Abstract available
    
    

    
    BMC Cancer

21. POMEY MP, Iliescu Nelea M, Vialaron C, Normandin L, et al
    The black box of the relationship between breast cancer patients and accompanying patients: the accompanied patients' point of view.
    BMC Cancer. 2024;24:822.
    PubMed         Abstract available
    
    

    
    BMJ

22. RIMMER A
    Navigating breastfeeding through cancer treatment.
    BMJ. 2024;386:q1284.
    PubMed        
    
    

    
    Br J Cancer

23. BESSE A, Sedlarikova L, Buechler L, Kraus M, et al
    HIV-protease inhibitors potentiate the activity of carfilzomib in triple-negative breast cancer.
    Br J Cancer. 2024 Jul 5. doi: 10.1038/s41416-024-02774.
    PubMed         Abstract available
    
    

    
    Breast Cancer

24. WEI JF, Li F, Lin JW, Dou ZA, et al
    Development and validation of a neoadjuvant chemotherapy pathological complete remission model based on Reg IV expression in breast cancer tissues: a clinical retrospective study.
    Breast Cancer. 2024 Jul 8. doi: 10.1007/s12282-024-01609.
    PubMed         Abstract available
    
    
25. LUO Y, Chen X, Lv R, Li Q, et al
    Breast-conserving surgery versus modified radical mastectomy in T1-2N3M0 stage breast cancer: a propensity score matching analysis.
    Breast Cancer. 2024 Jul 8. doi: 10.1007/s12282-024-01611.
    PubMed         Abstract available
    
    
26. PINELLI F, Barbani F, Defilippo B, Fundaro A, et al
    Quality of life in women with breast cancer undergoing neoadjuvant chemotherapy: comparison between PICC and PICC-port.
    Breast Cancer. 2024 Jul 9. doi: 10.1007/s12282-024-01608.
    PubMed         Abstract available
    
    
27. NAKAMOTO S, Iwamoto T, Taira N, Kajiwara Y, et al
    The effect of exercise and educational programs for breast cancer patients on the development of breast cancer-related lymphoedema: secondary endpoint from a randomized controlled trial in the Setouchi Breast Project-10.
    Breast Cancer. 2024 Jul 9. doi: 10.1007/s12282-024-01610.
    PubMed         Abstract available
    
    

    
    Breast Cancer (Dove Med Press)

28. BUYUKBAYRAM ME, Hannarici Z, Duzkopru Y, Turhan A, et al
    The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker.
    Breast Cancer (Dove Med Press). 2024;16:329-339.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res

29. KADER T, Provenzano E, Jayawardana MW, Hendry S, et al
    Stromal lymphocytes are associated with upgrade of B3 breast lesions.
    Breast Cancer Res. 2024;26:115.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res Treat

30. THOMPSON CN, Chandler J, Ju T, Tsai J, et al
    Residual cancer burden in two-stage nipple sparing mastectomy after first stage lumpectomy and devascularization of the nipple areolar complex.
    Breast Cancer Res Treat. 2024;207:143-149.
    PubMed         Abstract available
    
    
31. PAN K, Nelson RA, Chlebowski RT, Piela R, et al
    Ductal carcinoma in situ and cause-specific mortality among younger and older postmenopausal women: the Women's Health Initiative.
    Breast Cancer Res Treat. 2024;207:65-79.
    PubMed         Abstract available
    
    
32. ZENG A, Houssami N, Noguchi N, Nickel B, et al
    Frequency and characteristics of errors by artificial intelligence (AI) in reading screening mammography: a systematic review.
    Breast Cancer Res Treat. 2024;207:1-13.
    PubMed         Abstract available
    
    
33. ANDERSON SA, Bartow BB, Harada S, Siegal GP, et al
    p53 protein expression patterns associated with TP53 mutations in breast carcinoma.
    Breast Cancer Res Treat. 2024;207:213-222.
    PubMed         Abstract available
    
    
34. SIMMONS R, Kameyama H, Kubota S, Sun Y, et al
    Sustained delivery of celecoxib from nanoparticles embedded in hydrogel injected into the biopsy cavity to prevent biopsy-induced breast cancer metastasis.
    Breast Cancer Res Treat. 2024 Jul 5. doi: 10.1007/s10549-024-07410.
    PubMed         Abstract available
    
    
35. CHEN HW, Kuo WH, Lu YS, Chen IC, et al
    Interaction of base excision repair gene polymorphism and estrogen-DNA adducts in breast cancer risk among East Asian women.
    Breast Cancer Res Treat. 2024 Jul 5. doi: 10.1007/s10549-024-07418.
    PubMed         Abstract available
    
    
36. BRANTLEY KD, Tamimi RM
    The association between infectious agents and breast cancer: a review of the epidemiologic evidence.
    Breast Cancer Res Treat. 2024 Jul 6. doi: 10.1007/s10549-024-07388.
    PubMed         Abstract available
    
    
37. CHIDA K, Oshi M, Roy AM, Sato T, et al
    Enhanced cancer cell proliferation and aggressive phenotype counterbalance in breast cancer with high BRCA1 gene expression.
    Breast Cancer Res Treat. 2024 Jul 7. doi: 10.1007/s10549-024-07421.
    PubMed         Abstract available
    
    
38. SANJAYA A, Ratnawati H, Adhika OA, Rahmatilah FR, et al
    The heterogeneity of breast cancer metastasis: a bioinformatics analysis utilizing single-cell RNA sequencing data.
    Breast Cancer Res Treat. 2024 Jul 11. doi: 10.1007/s10549-024-07428.
    PubMed         Abstract available
    
    
39. DU KY, Wu S, Ma X, Liu Y, et al
    Circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers combined with clinicopathological risk has potential to better predict recurrence in stage III breast cancer treated with neoadjuvant chemotherapy: a pilot s
    Breast Cancer Res Treat. 2024 Jul 11. doi: 10.1007/s10549-024-07430.
    PubMed         Abstract available
    
    
40. KUMAR S, Ziegler Y, Plotner BN, Flatt KM, et al
    Resistance to FOXM1 inhibitors in breast cancer is accompanied by impeding ferroptosis and apoptotic cell death.
    Breast Cancer Res Treat. 2024 Jul 9. doi: 10.1007/s10549-024-07420.
    PubMed         Abstract available
    
    
41. LIANG E, Beshara M, Sheng H, Huang XW, et al
    A prospective study of vitamin D, proinflammatory cytokines, and risk of fragility fractures in women on aromatase inhibitors for breast cancer.
    Breast Cancer Res Treat. 2024 Jul 8. doi: 10.1007/s10549-024-07423.
    PubMed         Abstract available
    
    

    
    Cancer

42. ELGHAZALY H, Azim HA, Rugo HS, Cameron D, et al
    Tailoring neo/adjuvant systemic therapy in breast cancer: "The advent of a personalized approach"-The Breast-Gynecological and Immuno-Oncology International Cancer Conference (BGICC) consensus and recommendations.
    Cancer. 2024 Jul 10. doi: 10.1002/cncr.35389.
    PubMed         Abstract available
    
    

    
    Cancer Lett

43. ZHANG H, Zhang L, He Y, Jiang D, et al
    PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer.
    Cancer Lett. 2024 Jul 8:217112. doi: 10.1016/j.canlet.2024.217112.
    PubMed         Abstract available
    
    

    
    Cancer Res

44. IRIONDO O, Mecenas D, Li Y, Chin CR, et al
    Hypoxic Memory Mediates Prolonged Tumor Intrinsic Type I Interferon Suppression to Promote Breast Cancer Progression.
    Cancer Res. 2024 Jul 11. doi: 10.1158/0008-5472.CAN-23-2028.
    PubMed         Abstract available
    
    

    
    Clin Breast Cancer

45. EL KADDISSI A, Vernerey D, Falcoz A, Mansi L, et al
    Prognostic Factors for Long-Term Eribulin Response in a Cohort of Patients With HER2-Negative Metastatic Breast Cancer.
    Clin Breast Cancer. 2024 Jun 19:S1526-8209(24)00171.
    PubMed         Abstract available
    
    
46. CHEN AX, Chen X, Li XX, Guo ZY, et al
    Impacts of Tumor Stage at Diagnosis and Adjuvant Therapy on Long-Term Survival Outcomes in Patients With Triple-Negative Breast Cancer Achieving Pathologic Complete Response After Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2024 Jun 21:S1526-8209(24)00178.
    PubMed         Abstract available
    
    
47. MALKIELY G, Ashkenazi I, Malkin L, Zohar Y, et al
    Intraoperative diagnosis of breast cancer metastasis in axillary lymph nodes: Cytological Smear vs. Frozen Section.
    Clin Breast Cancer. 2024 Jun 7:S1526-8209(24)00150.
    PubMed         Abstract available
    
    
48. VUONG B, Jacinto AI, Chang SB, Kuehner GE, et al
    Contemporary Review of the Management and Treatment of Young Breast Cancer Patients.
    Clin Breast Cancer. 2024 Jun 7:S1526-8209(24)00148.
    PubMed         Abstract available
    
    
49. CASASANTA N, Patel R, Raymond S, Kier MW, et al
    Correlating Predicted Adjuvant Therapy Benefit and Risk of Recurrence Between Breast Cancer Index (BCI) and the 21-Gene Oncotype DX Recurrence Score (RS).
    Clin Breast Cancer. 2024 Jun 12:S1526-8209(24)00167.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

50. LLOMBART-CUSSAC A, Perez-Garcia J, Braso-Maristany F, Pare L, et al
    HER2DX Genomic Assay in HER2-positive Early Breast Cancer Treated with Trastuzumab and Pertuzumab: A Correlative Analysis from PHERGain Phase II Trial.
    Clin Cancer Res. 2024 Jul 12. doi: 10.1158/1078-0432.CCR-24-0464.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

51. GILL SS, Shukla A, Namireddy SR, Moin S, et al
    Exercise and recovery after surgery in patients with breast cancer: An analysis of the literature.
    Eur J Surg Oncol. 2024;50:108525.
    PubMed         Abstract available
    
    

    
    Eur Radiol

52. SARTOR H, Sturesdotter L, Larsson AM, Rosendahl AH, et al
    Mammographic features differ with body composition in women with breast cancer.
    Eur Radiol. 2024 Jul 12. doi: 10.1007/s00330-024-10937.
    PubMed         Abstract available
    
    
53. FALLENBERG EM
    Implementing the advantages of contrast-enhanced mammography and contrast-enhanced breast MRI in breast cancer staging.
    Eur Radiol. 2024 Jul 12. doi: 10.1007/s00330-024-10896.
    PubMed        
    
    

    
    Histopathology

54. TOZBIKIAN G, Bui MM, Hicks DG, Jaffer S, et al
    Best practices for achieving consensus in HER2-low expression in breast cancer: current perspectives from practising pathologists.
    Histopathology. 2024 Jul 8. doi: 10.1111/his.15275.
    PubMed         Abstract available
    
    

    
    Int J Cancer

55. BHIMANI J, O'Connell K, Persaud S, Blinder V, et al
    Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I-IIIA breast cancer.
    Int J Cancer. 2024 Jul 6. doi: 10.1002/ijc.35053.
    PubMed         Abstract available
    
    
56. JIANG C, Giaquinto AN, Jemal A, Sung H, et al
    Trends in breast cancer incidence by estrogen receptor status in the United States, 2004-2020.
    Int J Cancer. 2024 Jul 10. doi: 10.1002/ijc.35073.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

57. OKEYA A, Shimomura A, Kitagawa D, Shimizu C, et al
    Are Oral Selective Estrogen Receptor Degraders Beneficial for Patients With ESR1-Mutated Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast Cancer?
    J Clin Oncol. 2024 Jul 11:JCO2400992. doi: 10.1200/JCO.24.00992.
    PubMed        
    
    

    
    Nat Rev Cancer

58. HARRIS MA, Savas P, Virassamy B, O'Malley MMR, et al
    Towards targeting the breast cancer immune microenvironment.
    Nat Rev Cancer. 2024 Jul 5. doi: 10.1038/s41568-024-00714.
    PubMed         Abstract available
    
    

    
    NPJ Breast Cancer

59. HURVITZ SA, Bardia A, Punie K, Kalinsky K, et al
    Author Correction: Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer.
    NPJ Breast Cancer. 2024;10:55.
    PubMed        
    
    
60. RONCHI C, Haider S, Brisken C
    EMBER creates a unified space for independent breast cancer transcriptomic datasets enabling precision oncology.
    NPJ Breast Cancer. 2024;10:56.
    PubMed         Abstract available
    
    

    
    Oncogene

61. HAN X, Ren C, Lu C, Jiang A, et al
    Phosphorylation of USP27X by PIM2 promotes glycolysis and breast cancer progression via deubiquitylation of MYC.
    Oncogene. 2024 Jul 5. doi: 10.1038/s41388-024-03097.
    PubMed         Abstract available
    
    

    
    Pathology

62. LASHEN AG, Almalki N, Toss M, Mirza S, et al
    The characteristics and prognostic significance of histone H1 expression in breast cancer.
    Pathology. 2024 Jun 8:S0031-3025(24)00143-0. doi: 10.1016/j.pathol.2024.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

63. PERRONE MC, Lerner MG, Dunworth M, Ewald AJ, et al
    Prioritizing drug targets by perturbing biological network response functions.
    PLoS Comput Biol. 2024;20:e1012195.
    PubMed         Abstract available
    
    

    
    PLoS One

64. AHMAD J, Akram S, Jaffar A, Ali Z, et al
    Deep learning empowered breast cancer diagnosis: Advancements in detection and classification.
    PLoS One. 2024;19:e0304757.
    PubMed         Abstract available
    
    
65. LI X, Niu C, Yi G, Zhang Y, et al
    Quercetin inhibits the epithelial-mesenchymal transition and reverses CDK4/6 inhibitor resistance in breast cancer by regulating circHIAT1/miR-19a-3p/CADM2 axis.
    PLoS One. 2024;19:e0305612.
    PubMed         Abstract available
    
    

    
    Radiol Imaging Cancer

66. RESCH D, Lo Gullo R, Teuwen J, Semturs F, et al
    AI-enhanced Mammography With Digital Breast Tomosynthesis for Breast Cancer Detection: Clinical Value and Comparison With Human Performance.
    Radiol Imaging Cancer. 2024;6:e230149.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.